PDCD1 and systemic sclerosis: However, transforming growth factor beta (TGFβ) may be implicated, given its role in the pathogenesis of systemic sclerosis and that PD-1 inhibition results in TGFβ activation.[7] Furthermore, circulating levels of soluble PD-1 reportedly contribute to the development of systemic sclerosis.[10]